# Hangzhou Watson Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-watson-biotech

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.watsonbiotech.com
- Total disclosed funding: $7.2M
- Latest round: Series A (Dec 17, 2018)
- Investors on record: 2

## About

Based in Hangzhou, China and established in 2009, Hangzhou Watson Biotech, Inc. focuses on the development, manufacture and operation of detecting instrument and reagent for the field of liquid biopsy and medical diagnosis. Its products and services including circulating tumor cell (CTC) sorter, CTC detection systems, CTC auto scanner, epithelial cell detection reagent and tumor cell detection reagent and CTC detection services.

## Funding rounds

- Series A, Dec 17, 2018, $7.2M — Shenzhen Lucky Source Investment Management, Chongqing Dianshi Chuangjian Equity Investment Fund Management

## Investors

- Shenzhen Lucky Source Investment Management (https://capitalatlas.ai/funds/shenzhen-lucky-source-investment-management) — Series A
- Chongqing Dianshi Chuangjian Equity Investment Fund Management — Series A